541 related articles for article (PubMed ID: 3043338)
1. [Activity of 9 beta-lactam antibiotics combined with clavulanic acid or sulbactam against the strains of broad-spectrum beta-lactamase (CTX-1) producing Enterobacteriaceae isolated at the Henri Mondor Hospital].
Legrand P; Soussy CJ; Orsoni A; Brickley X; Duval J
Pathol Biol (Paris); 1988 May; 36(5):425-9. PubMed ID: 3043338
[TBL] [Abstract][Full Text] [Related]
2. [Comparative activities of 15 beta-lactam antibiotics against 590 strains of Klebsiella pneumoniae according to the production of beta-lactamase].
Bercion R; Meyran M; Labia R; Thabaut A
Pathol Biol (Paris); 1991 May; 39(5):353-60. PubMed ID: 1881669
[TBL] [Abstract][Full Text] [Related]
3. In-vitro activity of FCE 22101 and other beta-lactam antibiotics against Enterobacteriaceae resistant to third generation cephalosporins.
Jarlier V; Nicolas MH; Philippon A; Giroir AM; Grosset J
J Antimicrob Chemother; 1989 Aug; 24(2):165-72. PubMed ID: 2676939
[TBL] [Abstract][Full Text] [Related]
4. [Antibacterial effect of cefixime in the presence of the type of beta-lactamases produced by Enterobacteriaceae].
Philippon A; Jarlier V; Legrand P; Fournier G; Nicolas MH; Duval J
Presse Med; 1989 Oct; 18(32):1560-6. PubMed ID: 2530532
[TBL] [Abstract][Full Text] [Related]
5. In vivo selection of Enterobacter aerogenes with reduced susceptibility to cefepime and carbapenems associated with decreased expression of a 40 kDa outer membrane protein and hyperproduction of AmpC beta-lactamase.
Fernández-Cuenca F; Rodríguez-Martínez JM; Martínez-Martínez L; Pascual A
Int J Antimicrob Agents; 2006 Jun; 27(6):549-52. PubMed ID: 16697150
[TBL] [Abstract][Full Text] [Related]
6. [Continuous surveillance of antimicrobial resistance among nosocomial gram-negative bacilli from intensive care units in China].
Chen MJ; Wang H;
Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):375-81. PubMed ID: 12820912
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
[TBL] [Abstract][Full Text] [Related]
8. [Variation in transfer resistance to cefotaxime, ceftazidime and aztreonam in strains of Acinetobacter sp., Enterobacter sp. and Citrobacter sp. isolated from the same university hospitals].
Babálová M; Krălíková K; Krcméry V; Kubonová K
Cas Lek Cesk; 1996 Mar; 135(6):181-4. PubMed ID: 8681362
[TBL] [Abstract][Full Text] [Related]
9. [Development of Beta-lactamase resistance in enterobacteria].
Koren J; Vaculíková A
Klin Mikrobiol Infekc Lek; 2006 Jun; 12(3):103-7. PubMed ID: 17051471
[TBL] [Abstract][Full Text] [Related]
10. Post-antibiotic and post-beta-lactamase inhibitor effects of ceftazidime plus sulbactam on extended-spectrum beta-lactamase-producing Gram-negative bacteria.
Lavigne JP; Bonnet R; Michaux-Charachon S; Jourdan J; Caillon J; Sotto A
J Antimicrob Chemother; 2004 Apr; 53(4):616-9. PubMed ID: 14985275
[TBL] [Abstract][Full Text] [Related]
11. [Extended-spectrum beta-lactamase in Klebsiella pneumoniae and Escherichia coli isolates].
Xiong Z; Zhu D; Zhang Y; Wang F
Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1476-9. PubMed ID: 12509910
[TBL] [Abstract][Full Text] [Related]
12. In vitro activities of antibacterial agents against clinical isolates of Escherichia coli and Klebsiella species from intensive care units.
Gill CJ; Ponticas S; Shungu DL; Guerriero S
Clin Ther; 1991; 13(1):25-37. PubMed ID: 2029725
[TBL] [Abstract][Full Text] [Related]
13. Resistance of strains producing extended-spectrum beta-lactamases and genotype distribution in China.
Yu Y; Ji S; Chen Y; Zhou W; Wei Z; Li L; Ma Y
J Infect; 2007 Jan; 54(1):53-7. PubMed ID: 16533535
[TBL] [Abstract][Full Text] [Related]
14. [Antibiotic activity and synergism of ceftazidime and netilmicin against gram-negative pathogenic bacteria].
Baumgärtner M; Müller HP; Wundt W
Arzneimittelforschung; 1983; 33(12):1615-9. PubMed ID: 6320836
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic characteristics of clinical isolates of Klebsiella pneumoniae & evaluation of available phenotypic techniques for detection of extended spectrum beta-lactamases.
Manchanda V; Singh NP; Goyal R; Kumar A; Thukral SS
Indian J Med Res; 2005 Oct; 122(4):330-7. PubMed ID: 16394326
[TBL] [Abstract][Full Text] [Related]
16. In vitro activities of beta-lactam antibiotics alone and in combination with sulbactam against Gram-negative bacteria.
Wang FD; Lin ML; Lee WS; Liu CY
Int J Antimicrob Agents; 2004 Jun; 23(6):590-5. PubMed ID: 15194130
[TBL] [Abstract][Full Text] [Related]
17. [In vitro activity of meropenem and seven other beta-lactam antibiotics against K.pneumoniae and enterobacteriaceae producing beta-lactamases with extended spectrum].
Cavallo JD; Fabre R; Crenn Y; Meyran M
Pathol Biol (Paris); 1994 May; 42(5):365-8. PubMed ID: 7824297
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a new cefepime-clavulanate ESBL Etest to detect extended-spectrum beta-lactamases in an Enterobacteriaceae strain collection.
Stürenburg E; Sobottka I; Noor D; Laufs R; Mack D
J Antimicrob Chemother; 2004 Jul; 54(1):134-8. PubMed ID: 15150168
[TBL] [Abstract][Full Text] [Related]
19. Effects of phenotype and genotype on methods for detection of extended-spectrum-beta-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway.
Tofteland S; Haldorsen B; Dahl KH; Simonsen GS; Steinbakk M; Walsh TR; Sundsfjord A;
J Clin Microbiol; 2007 Jan; 45(1):199-205. PubMed ID: 17079502
[TBL] [Abstract][Full Text] [Related]
20. Occurrence of extended-spectrum beta-lactamases among chromosomal AmpC-producing Enterobacter cloacae, Citrobacter freundii, and Serratia marcescens in Korea and investigation of screening criteria.
Park YJ; Park SY; Oh EJ; Park JJ; Lee KY; Woo GJ; Lee K
Diagn Microbiol Infect Dis; 2005 Apr; 51(4):265-9. PubMed ID: 15808318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]